Abstract
To compare the thermotolerancein vivo of two human gastric cancers with different doubling times, the xenografted tumors were warmed twice at 43.5±0.1°C in a water bath for 20 minutes at a predetermined interval. In the tumors with doubling times of 5.2 and 10.9 days, a 7-day interval heat treatment resulted in a prolongation in tumor tripling times by 156 per cent and 132 per cent, respectively, compared with a single heat treatment for 40 minutes. On the contrary, two heat treatments given at intervals of 3 to 5 days had a short tumor tripling time, compared to that of the 40-minute single treatment. Thus, the thermotolerance of these human gastric cancers gradually increased to a maximum within a 3- to 4-day interval and disappeared completely after a 7-day interval. These results indicate that the times required to reach maximal thermotolerance in these human gastric cancers were longer than those previously demonstrated for human and rodent cancer cell linesin vitro. The development and decay of thermotolerance in these human gastric cancers need to be considered in the design of multiple-fractionated regimens.
Similar content being viewed by others
References
Urano M. Kinetics of thermotolerance in normal and tumor tissues: a review. Cancer Res 1986; 46: 474–482.
Law MP. The induction of thermal resistance in the ear of the mouse by heating at temperature ranging from 41.5 to 45.5°C. Radiat Res 1981; 85: 126–134.
Yoshihara T. Experimental studies on thermotolerance in hyperthermia treatment for cancer. J Jpn Surg Soc 1987; 88: 663–674.
Rhee JG, Schuman VL, Song CW, Levitt SH. Difference in the thermotolerance of mouse mammary carcinoma cellsin vitro andin vitro. Cancer Res 1987; 47: 2571–2575.
Rofstad EK, Brustad T. Development of thermotolerance in a human melanoma xenograft. Cancer Res 1984; 44: 525–530.
Koga S, Maeta M, Shimizu N, Osaki Y, Hamazoe R, Oda M, Karino T, Yamane T. Clinical effects of total-body hyperthermia combined with anticancer chemotherapy for far-advanced gastrointetinal cancer. Cancer 1985; 55: 1641–1647.
Fujimoto S, Ohta M, Shrestha RD, Kokubun M, Miyoshi T, Mori T, Okui K. Enhancement of hyperthermochemotherapy for human gastric cancer in nude mice by thermosensitization with nitroimidazole. Br J Cancer 1988; 58: 42–45.
Nielsen OS, Overgaard J. Importance of preheating temperature and time for the induction of thermotolerance in a solid tumourin vivo. Br J Cancer 1982; 46: 894–903.
Kamura T, Nielsen OS, Overgaard J, Andersen AH. Development of thermotolerance during fractionated hyperthermia in a solid tumorin vivo. Cancer Res 1982; 42: 1744–1748.
Henle KJ. Discussion on “The role of tissue environmental factors on the kinetics and morphology of tumor cells exposed to hyperthermia” by Overgaard J, Nielsen OS. Ann NY Acad Sci 1980; 335: 279–280.
Song CW, Kang MS, Rhee JG, Levitt SH. The effect of hyperthermia on vascular function, pH, and cell survival. Radiology 1980; 137: 795–803.
Bicher HI, Hetzel FW, Sandhu TS, Frinak S, Vaupel P, O'Hara MD, O'Brien T. Effect of hyperthermia on normal and tumor microenvironment. Radiology 1980; 137: 523–530.
Kokubun M, Fujimoto S, Shrestha RD, Ohta M, Kobayashi K, Koike S, Okui K, Takahashi M, Fujita M, Taguchi T. Evaluation of thermotolerance due to TpO2 of malignant tissue. In: Koga S ed. Hyperthermic Oncology. Yonago, Japan: Imai Printing & Publishing Co. Ltd. 1987; 227–228.
Landry J, Bernier D, Chretien P, Nicole LM, Tanguay RM, Marceau N. Synthesis and degradation of heat shock proteins during development and decay of thermotolerance. Cancer Res 1982; 42: 2457–2461.
Burdon RH, Slater A, McMahon M, Cato ACB. Hyperthermia and the heat-shock proteins of HeLa cells. Br J Cancer 1982; 45: 953–963.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fujimoto, S., Ohta, M., Shrestha, R.D. et al. Thermotolerance of xenografted human gastric cancer. The Japanese Journal of Surgery 19, 203–207 (1989). https://doi.org/10.1007/BF02471586
Issue Date:
DOI: https://doi.org/10.1007/BF02471586